How Beyer was paid
$7.6M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Patrick J. BeyerPresident and Chief Executive Officer | $891,100 | — | $2,499,971 | $2,499,977 | $1,129,469 | $614,356 | $7,634,873 |
| Todd W. GarnerExecutive Vice President, Finance and Chief Financial Officer | $610,000 | — | $500,096 | $1,499,990 | $659,354 | $27,956 | $3,297,396 |
| Hollie FoustExecutive Vice President, General Counsel and Corporate Secretary | $457,500 | — | $250,005 | $750,007 | $378,159 | $7,105 | $1,842,776 |
| Brent LalomiaExecutive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations | $424,499 | $50,000 | $218,721 | $656,238 | $276,073 | $37,245 | $1,662,776 |
| Peter K. ShagoryExecutive Vice President, Strategy and Corporate Development | $385,963 | — | $212,534 | $637,499 | $320,529 | $7,264 | $1,563,789 |
What changed and why
- Patrick J. Beyer became President and CEO effective January 1, 2025.
- $7.6MCEO total compensation was $7,634,873 in fiscal 2025.
- 97%Stockholders approved the prior say-on-pay proposal with approximately 97% support.
- The ratio of the CEO to median employee annual total compensation was 152 to 1.
- Equity awards for the CEO were split evenly between stock options and performance stock units.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.